Navigation Links
UTMB awarded $4.4M to develop universal flu vaccine
Date:5/7/2014

Researchers at the University of Texas Medical Branch are working to create a universal flu vaccine one that could eliminate the need for an annual flu shot.

If approved for general use, the vaccine would be a public health breakthrough not only in preventing influenza in the United States but most importantly in the developing world, where the virus can have much more devastating effects due to the challenge of vaccinating these populations every year.

Thanks to a $4.4 million grant from the National Institute of Allergy and Infectious Diseases, UTMB researchers and Seattle-based biotechnology company Etubics Corporation plan to construct, produce and test a vaccine containing various antigens of the A and B strains of influenza.

If successful, clinicians could have a vaccine that recognizes all influenza viruses, not just a single type, ready for patients within five years, according to Dr. Frank Jones, chairman and chief executive officer of Etubics.

Co-principal investigator Dr. Slobodan Paessler, a professor in the UTMB Department of Pathology and director of the Preclinical Studies Core in the Galveston National Laboratory, said that UTMB has one of the most comprehensive university-based vaccine development programs in the world.

"UTMB also has broad capabilities in the area of vaccine development and infectious diseases," he said. "We believe these resources provide an excellent infrastructure to support this project as it moves forward through the vaccine development pathway to ultimately become a licensed vaccine."

Vaccine development is one of the most ambitious of scientific undertakings, often taking several years and at least a half billion dollars for a vaccine to go from the lab to clinical trials to common use. There are only about 50 vaccines approved worldwide today.

UTMB researchers have earned worldwide recognition for their contributions to the field, and today are focusing on developing vaccines not only for infectious diseases but also aging-related chronic illnesses such as heart disease, diabetes, cancer and Alzheimer's disease.


'/>"/>

Contact: Kristen Hensley
k.hensley@utmb.edu
409-772-8772
University of Texas Medical Branch at Galveston
Source:Eurekalert

Related medicine news :

1. Scientist awarded $1 million grant to develop tools for hepatitis C treatment discovery
2. $9 million grant awarded to UH to study, treat learning disabilities
3. Kessler Foundation scientist awarded $554,000 for multiple sclerosis employment research
4. Moffitt researcher awarded GE grant to develop tool to detect breast cancer metastasis genetic risks
5. Grant awarded to help improve problem-solving skills for deaf and hard-of-hearing students
6. Southeast program to fight diabetes awarded nearly $10 million by HHS
7. Clemson professor awarded nearly $600,000 4-year grant to study language of plants
8. 29 Johns Hopkins stem cell researchers awarded funding
9. Einstein awarded $6 million grant to develop new TB vaccine against drug-resistant strains
10. FirstVitals Health and Wellness, Inc. awarded $4 Million CMS Innovation Grant for Unique Telehealth Diabetes Progam Focused on Glycemic Control and Prevention of Diabetic Foot Complications
11. EMBO Gold Medal 2012 awarded to Jiri Friml
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... ... January 21, 2017 , ... Phytocéane invites you to ... the rest of the world with ZANZIBAR SHOWER GEL. Inspired by the beauty of ... Virgin Coconut Oil and moisturizing vegetal coral to create this gentle, crystal-clear shower gel ...
(Date:1/21/2017)... ... January 21, 2017 , ... The Nobel Biocare™ dental ... in media for its creos™ line of bone regenerative products. Specifically, the ... which he utilizes creos™ allo.gain™ bone graft for a variety of bone reconstruction ...
(Date:1/20/2017)... Boca Raton, FL (PRWEB) , ... January 20, 2017 , ... ... supplement development, announced it attended the January ECRM trade show to continue the marketing ... technologically advanced vitamin C supplement, known for providing 400 percent better absorption than traditional ...
(Date:1/20/2017)... ... ... Michael and Betsy Brauser celebrated 5 years of Betsy’s participation in a ... has been life-saving as she has been on the trial for more than six ... ovarian cancer in 2009. She underwent standard chemotherapy but a year later went to ...
(Date:1/20/2017)... ... ... biographical account following a man who went on to support his country and serve the ... Lynn Haven, Florida and at the age of 5, his family moved to Pensacola Florida. ... Navy and got married right out of boot camp. , He and his wife ...
Breaking Medicine News(10 mins):
(Date:1/20/2017)... 2017  Ethicon Endo-Surgery, Inc. announced today ... Inc., a privately held medical device company ... used in operating rooms worldwide. The acquisition ... energy devices with Megadyne,s innovative portfolio of ... in Ethicon,s goal to deliver the most ...
(Date:1/20/2017)... -- Wells Specialty Pharmacy announces the acquisitions and merger of ... Winter Park, Florida and Pharm-EZ Medical, LLC, ... been consolidated into the 3796 Howell Branch Road Facility. ... Chad Tomlinson , former Vice President of Operations, has ... Tomlinson is a Graduate of Florida State University and has ...
(Date:1/19/2017)... The global immunomodulators market is expected ... to a new study by Grand View Research, ... driven by high R&D investments employed by the ... new and therapeutically advanced drugs. This is believed ... unprecedented rate into the immunomodulators market hence providing ...
Breaking Medicine Technology: